UNSPSC 51152076: Mivacurium chloride

This classification denotes a muscle relaxant with the molecular formula C58H80N2O14.2Cl, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 600ZG213C3, chemically known as (r)-1,2,3,4-tetrahydro-2-(3-hydroxypropyl)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium chloride, (e)-4-octenedioate (2:1) but more generally known as mivacurium chloride, which bears U.S. National Institutes of Health Compound Identifier 5281080.

UNSPSC 51152076 Mivacurium chloride, a Commodity code, nominally covers a specific neuromuscular blocking agent used in anesthesia. State and local procurement activity under this code does not align with the pharmaceutical scope: the single recent opportunity on record is a Seminole County, Florida IFB for naloxone and safe drug deactivation systems, which are harm-reduction and emergency-response products fundamentally unrelated to mivacurium chloride. The code shows negligible recent activity in state and local procurement and does not currently represent an active market segment for vendors pursuing municipal or county contracts.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023, and bids to be submitted electronically through the county's e-Procurement Portal. The contract carries a two-year initial term plus one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and is potentially funded through FEMA. The mismatch between the code's nominal pharmaceutical scope and the actual procurement content suggests either a data-entry error in the opportunity classification or an obsolete code assignment; the code itself does not represent meaningful state and local buying activity at this time.